Back to Search
Start Over
S1635 ACADEMIC, PHASE1 TRIAL ON T CELLS EXPRESSING BOTH CD19 CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA AND NON-HODGKIN LYMPHOMA
- Source :
- HemaSphere. 3:755
- Publication Year :
- 2019
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2019.
Details
- ISSN :
- 25729241
- Volume :
- 3
- Database :
- OpenAIRE
- Journal :
- HemaSphere
- Accession number :
- edsair.doi...........db7ef1012403aa3ee28e942b918c4874